Salidroside suppresses cell growth and inflammatory response of fibroblast-like synoviocytes via inhibition of phosphoinositol-3 kinase/threonine kinase signaling in rheumatoid arthritis-Reference-Cited by-同舟云学术

Salidroside suppresses cell growth and inflammatory response of fibroblast-like synoviocytes via inhibition of phosphoinositol-3 kinase/threonine kinase signaling in rheumatoid arthritis

Published:2023-10-18 Issue: Volume: Page:
ISSN:0340-1855
Container-title:Zeitschrift für Rheumatologie
language:en
Short-container-title:Z Rheumatol

Author:

Qin Yajing,Su Juan

Publisher

Springer Science and Business Media LLC

Subject

Rheumatology

Link

https://link.springer.com/content/pdf/10.1007/s00393-023-01431-5.pdf

Reference39 articles.

1. Sparks JA (2019) Rheumatoid Arthritis. Ann Intern Med 170(1):Itc1

2. Bottini N, Firestein GS (2013) Duality of fibroblast-like synoviocytes in RA: passive responders and imprinted aggressors. Nat Rev Rheumatol 9(1):24–33

3. Chen Z et al (2019) Anti-inflammatory and immune-regulatory cytokines in rheumatoid arthritis. Nat Rev Rheumatol 15(1):9–17

4. Bartok B, Firestein GS (2010) Fibroblast-like synoviocytes: key effector cells in rheumatoid arthritis. Immunol Rev 233(1):233–255

5. Korb-Pap A et al (2016) Stable activation of fibroblasts in rheumatic arthritis-causes and consequences. Rheumatology 55(suppl 2):ii64–ii67

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Salidroside: A Promising Agent in Bone Metabolism Modulation;Nutrients;2024-07-23

2. Modulation of atherosclerosis‐related signaling pathways by Chinese herbal extracts: Recent evidence and perspectives;Phytotherapy Research;2024-04-05

3. Mechanism of Rhodiola rosea–Euonymus alatus drug pair against rheumatoid arthritis: Network pharmacology and experimental validation;Immunity, Inflammation and Disease;2023-12

4. Integrated Network Pharmacology and Experimental Approach to Investigate the Protective Effect of Jin Gu Lian Capsule on Rheumatoid Arthritis by Inhibiting Inflammation via IL-17/NF-κB Pathway;Drug Design, Development and Therapy;2023-12